Shery Chow

$2,676,421

Attributed

$2,676,421

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.4M · FY2014–20

$2M$1.5M$1M$500K$0

'14

'15

'16

'17

'18

'19

'20

Funding mix

By agency

NIH$2,676,421 · 1

By mechanism

N01$2,676,421 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Arizona”

Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$129,913,532
Patrick J McCarthy · Carnegie Institution Of Washington$122,566,447
Eric M Reiman · Banner Health$60,834,580
Lori E Allen · Association Of Universities For Research In Astronomy, Inc.$59,454,843
David R. Silva · Association Of Universities For Research In Astronomy, Inc.$43,574,944
Jennifer Lotz · Johns Hopkins University$39,961,632

Research focus

ArizonaBenignParticipantPost InterventionPsa LevelRandomizedRandomized Placebo Controlled TrialResponseSerum PsaStainsSubgroupTissuesTumorTumor TissueUniversitiesVaccinesCd8b1 GeneCellsContractorContractsEvaluationExerciseImmuneMagnetic Resonance Imaging

Grant awards (4)

PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PROSTVAC (PSA-TRICOM) IN PATIENTS... (PROTOCOL UAZ2012-03-01). CONTRACTOR: UNIVERSITY OF ARIZONA. CONTRACT: HHSN261201200031I. PERIOD: 9$168,543

N01 · FY2020 · CA · contact PI

PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PROSTVAC (PSA-TRICOM) IN PATIENTS... (PROTOCOL UAZ2012-03-01). CONTRACTOR: UNIVERSITY OF ARIZONA. CONTRACT: HHSN261201200031I. PERIOD: 9$116,867

N01 · FY2019 · CA · contact PI

402 -- TITLE: PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PROSTVAC (PSA-TRICOM) IN PATIENTS... (PROTOCOL UAZ2012-03-01). CONTRACTOR: UNIVERSITY OF ARIZONA. CONTRACT: HHSN261201200031I. PERIOD: 9$948,936

N01 · FY2016 · CA · contact PI

N01 · FY2014 · CA · contact PI